Clicky

Advanced Oncotherapy Plc(AVO)

Description: Advanced Oncotherapy Plc is focused on providing radiotherapy systems for cancer treatment through the use of a proton therapy technology. The Company is engaged in development and then building of the Linac Image Guided Hadron Technology (LIGHT) proton beam cancer therapy device and management of healthcare related property. The Company's segments include Development of Proton Therapy-UK; Development of Proton Therapy-Switzerland; Development of Proton Therapy-USA, and Healthcare-related properties-UK. Its LIGHT system uses accelerators, which is a series of modular units. This feature offers hospitals and centers to customize treatment plans based on a range of energies. The Company's Research and development/ADAM S.A. (R&D/ADAM) facility is located on the campus of European Council for Nuclear Research (CERN), Geneva, Switzerland, and a manufacturing plant, clinical research and clinician training facility in Syracuse, the United States.


Keywords: Natural Sciences Cancer Clinic Cancer Treatment Hospital Radio Medical Physics Physics Clinical Research Radiation Therapy Radiotherapy Radiobiology Manufacturing Plant Treating Cancer Adam Cancer Therapy Proton Proton Therapy Accelerator Physics Cern

Home Page: www.avoplc.com

AVO Technical Analysis

4 Tenterden Street
London, W1S 1TE
United Kingdom
Phone: 44 20 3617 8728


Officers

Name Title
Dr. Michael Jeffrey Sinclair Exec. Chairman
Mr. Nicolas Serandour CEO & Exec. Director
Prof. Stephen Myers OBE Exec. Director
Mr. Ed Lee COO & Pres of Europe
Mr. Graham Pughe Sr. Vice-Pres of Accounting
Ms. Berengere Pons-Chabord Sr. Vice-Pres of Corp. Fin.
Dr. Manuel Gallas Director of Technical & Engineering
Mr. David Navas VP of Investor and PR
Ms. Bridget Biggar Director of HR
Ms. Donatella Ungaro Managing Director of ADAM

Exchange: LSE

Country: UK

Currency: Pence sterling (p)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 1.4709
Price-to-Sales TTM: 0
IPO Date:
Fiscal Year End: December
Full Time Employees: 174
Back to stocks